Type 2 Diabetes Management, Control and Outcomes During the COVID-19 Pandemic in Older US Veterans: an Observational Study.
Type 2 Diabetes Management, Control and Outcomes During the COVID-19 Pandemic in Older US Veterans: an Observational Study.
复制标题
2型糖尿病的管理,控制和结果在美国老年退伍军人的大流行期间:一项观察性研究。
DOI:
10.1007/s11606-021-07301-7
复制
发表时间:
2022-03
影响因子:
5.7
通讯作者:
Hofer TP
中科院分区:
文献类型:
--
作者:
Aubert CE;Henderson JB;Kerr EA;Holleman R;Klamerus ML;Hofer TP
The COVID-19 pandemic required a change in outpatient care delivery models, including shifting from in-person to virtual visits, which may have impacted care of vulnerable patients. To describe the changes in management, control, and outcomes in older people with type 2 diabetes (T2D) associated with the shift from in-person to virtual visits. In veterans aged ≥ 65 years with T2D, we assessed the rates of visits (in person, virtual), A1c measurements, antidiabetic deintensification/intensification, ER visits and hospitalizations (for hypoglycemia, hyperglycemia, other causes), and A1c level, in March 2020 and April–November 2020 (pandemic period). We used negative binomial regression to assess change over time (reference: pre-pandemic period, July 2018 to February 2020), by baseline Charlson Comorbidity Index (CCI; > 2 vs. <= 2) and A1c level. Among 740,602 veterans (mean age 74.2 [SD 6.6] years), there were 55% (95% CI 52–58%) fewer in-person visits, 821% (95% CI 793–856%) more virtual visits, 6% (95% CI 1–11%) fewer A1c measurements, and 14% (95% CI 10–17%) more treatment intensification during the pandemic, relative to baseline. Patients with CCI > 2 had a 14% (95% CI 12–16%) smaller relative increase in virtual visits than those with CCI <= 2. We observed a seasonality of A1c level and treatment modification, but no association of either with the pandemic. After a decrease at the beginning of the pandemic, there was a rebound in other-cause (but not hypo- and hyperglycemia-related) ER visits and hospitalizations from June to November 2020. Despite a shift to virtual visits and a decrease in A1c measurement during the pandemic, we observed no association with A1c level or short-term T2D-related outcomes, providing some reassurance about the adequacy of virtual visits. Further studies should assess the longer-term effects of shifting to virtual visits in different populations to help individualize care, improve efficiency, and maintain appropriate care while reducing overuse. The online version contains supplementary material available at 10.1007/s11606-021-07301-7.
登录
查看更多内容
影响因子:
2.3
作者:
Irmak, Aylin Y.;Celikkalp, Ulfiye;Ekuklu, Galip
通讯作者:
Ekuklu, Galip
DOI:
10.1016/j.ajem.2020.11.029
发表时间:
2021-04
期刊:
The American journal of emergency medicine
影响因子:
--
作者:
Nourazari S;Davis SR;Granovsky R;Austin R;Straff DJ;Joseph JW;Sanchez LD
通讯作者:
Sanchez LD
影响因子:
33.9
作者:
Moreland, Amanda;Herlihy, Christine;Baldwin, Grant
通讯作者:
Baldwin, Grant
影响因子:
3.5
作者:
Kendzerska T;Zhu DT;Gershon AS;Edwards JD;Peixoto C;Robillard R;Kendall CE
通讯作者:
Kendall CE
DOI:
10.1161/circoutcomes.112.966697
发表时间:
2013-01-01
期刊:
Circulation. Cardiovascular quality and outcomes
影响因子:
--
作者:
Beard AJ;Hofer TP;Downs JR;Lucatorto M;Klamerus ML;Holleman R;Kerr EA;Diabetes Clinical Action Measures Workgroup
通讯作者:
Diabetes Clinical Action Measures Workgroup